Literature DB >> 11389089

Apoptotic triggers initiate translocations within the MLL gene involving the nonhomologous end joining repair system.

C J Betti1, M J Villalobos, M O Diaz, A T Vaughan.   

Abstract

Translocations involving the MLL gene at 11q23 are a frequent finding in therapy-related leukemia and are concentrated within a short, 8.3-kb tract of DNA, the breakpoint cluster region. In addition, a specific site adjacent to exon 12 within this region of MLL is cleaved in cells undergoing apoptosis. We show here, using human TK6 lymphoblastoid cells, that irradiation and the apoptotic trigger anti-CD95 antibody are each able to initiate translocations at the MLL exon 12 cleavage site. The translocation junctions produced contain regions of microhomology consistent with operation of the nonhomologous end joining (NHEJ) repair process. Participation of the NHEJ process is supported by the identification of the NHEJ component DNA-PKcs at the site of apoptotic cleavage. Suppression of DNA-PKcs function by the phosphatidylinositol 3-kinase inhibitor wortmannin compromises DNA end joining, increases site-specific cleavage within MLL, and eliminates MLL-restricted translocations. We propose that activation of apoptotic effector nucleases alone is sufficient to generate proleukemogenic translocations and raises the possibility that some of these may persist in cells that evade apoptotic execution and survive.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11389089

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  37 in total

1.  Suberoylanilide hydroxyamic acid modification of chromatin architecture affects DNA break formation and repair.

Authors:  Sheetal Singh; Hongan Le; Shyh-Jen Shih; Bay Ho; Andrew T Vaughan
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-02-01       Impact factor: 7.038

2.  Evidence for direct involvement of epirubicin in the formation of chromosomal translocations in t(15;17) therapy-related acute promyelocytic leukemia.

Authors:  Ashley N Mays; Neil Osheroff; Yuanyuan Xiao; Joseph L Wiemels; Carolyn A Felix; Jo Ann W Byl; Kandeepan Saravanamuttu; Andrew Peniket; Robert Corser; Cherry Chang; Christine Hoyle; Anne N Parker; Syed K Hasan; Francesco Lo-Coco; Ellen Solomon; David Grimwade
Journal:  Blood       Date:  2009-11-02       Impact factor: 22.113

3.  Zinc Finger Nuclease induced DNA double stranded breaks and rearrangements in MLL.

Authors:  To Uyen Do; Bay Ho; Shyh-Jen Shih; Andrew Vaughan
Journal:  Mutat Res       Date:  2013-01-02       Impact factor: 2.433

4.  Premature transcript termination, trans-splicing and DNA repair: a vicious path to cancer.

Authors:  Eric Kowarz; Jennifer Merkens; Michael Karas; Theo Dingermann; Rolf Marschalek
Journal:  Am J Blood Res       Date:  2011-04-07

5.  Roles of DNA topoisomerase II isozymes in chemotherapy and secondary malignancies.

Authors:  Anna M Azarova; Yi Lisa Lyu; Chao-Po Lin; Yuan-Chin Tsai; Johnson Yiu-Nam Lau; James C Wang; Leroy F Liu
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-19       Impact factor: 11.205

6.  Efficient repair of DNA double-strand breaks in malignant cells with structural instability.

Authors:  Yue Cheng; Zhenhua Zhang; Bridget Keenan; Anna V Roschke; Kenneth Nakahara; Peter D Aplan
Journal:  Mutat Res       Date:  2010-01-05       Impact factor: 2.433

Review 7.  Molecular biology of therapy-related leukaemias.

Authors:  Melanie Joannides; David Grimwade
Journal:  Clin Transl Oncol       Date:  2010-01       Impact factor: 3.405

8.  Multiple clonal MLL fusions in a patient receiving CHOP-based chemotherapy.

Authors:  Shyh-Jen Shih; Joseph Fass; Vincent Buffalo; Dawei Lin; Sheetal P Singh; Manuel O Diaz; Andrew T Vaughan
Journal:  Br J Haematol       Date:  2012-07-30       Impact factor: 6.998

Review 9.  Cytogenetic instability in childhood acute lymphoblastic leukemia survivors.

Authors:  María Sol Brassesco; Danilo Jordão Xavier; Marjori Leiva Camparoto; Ana Paula Montaldi; Paulo Roberto D'Auria Vieira de Godoy; Carlos Alberto Scrideli; Luiz Gonzaga Tone; Elza Tiemi Sakamoto-Hojo
Journal:  J Biomed Biotechnol       Date:  2010-08-31

Review 10.  The molecular biology of mixed lineage leukemia.

Authors:  Robert K Slany
Journal:  Haematologica       Date:  2009-06-16       Impact factor: 9.941

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.